These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3101289)

  • 21. Hbc ag, anti-HBC, and DNA polymerase activity in transfused recipients followed prospectively.
    Hollinger FB; Dressman GR; Fields H; Melnick J
    Am J Med Sci; 1975; 270(2):343-8. PubMed ID: 1235476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective controlled study of post-transfusion hepatitis after cardiac surgery in a large referral hospital in India.
    Dasarathy S; Misra SC; Acharya SK; Irshad M; Joshi YK; Venugopal P; Tandon BN
    Liver; 1992 Jun; 12(3):116-20. PubMed ID: 1323739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study.
    Aach RD; Szmuness W; Mosley JW; Hollinger FB; Kahn RA; Stevens CE; Edwards VM; Werch J
    N Engl J Med; 1981 Apr; 304(17):989-94. PubMed ID: 6782484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion.
    Allain JP; Hewitt PE; Tedder RS; Williamson LM
    Br J Haematol; 1999 Oct; 107(1):186-95. PubMed ID: 10520040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The usefulness of surrogate markers anti-HBc and ALT for post-transfusion non-A, non-B hepatitis prevention.
    Richard D
    J Virol Methods; 1987 Aug; 17(1-2):105-17. PubMed ID: 3117828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-transfusion non-A, non-B hepatitis: significance of raised ALT and anti-HBc in blood donors.
    Gillon J; Hussey AJ; Howe SP; Beckett GJ; Prescott RJ
    Vox Sang; 1988; 54(3):148-53. PubMed ID: 3130726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group.
    Blajchman MA; Bull SB; Feinman SV
    Lancet; 1995 Jan; 345(8941):21-5. PubMed ID: 7528310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study Group.
    Busch MP; Dodd RY; Lackritz EM; AuBuchon JP; Birkmeyer JD; Petersen LR
    Transfusion; 1997 Oct; 37(10):1003-11. PubMed ID: 9354817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.
    Busch MP
    Vox Sang; 1998; 74 Suppl 2():147-54. PubMed ID: 9704438
    [No Abstract]   [Full Text] [Related]  

  • 30. Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomes.
    Mosley JW; Huang W; Stram DO; Nowicki MJ; Hollinger FB; Aach RD; Stevens CE; Barbosa LH; Nemo GJ
    Transfusion; 1996 Sep; 36(9):776-81. PubMed ID: 8823449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.
    Hoofnagle JH; Seeff LB; Bales ZB; Zimmerman HJ
    N Engl J Med; 1978 Jun; 298(25):1379-83. PubMed ID: 652005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion.
    Morris JA; Wilcox TR; Reed GW; Hunter EB; Wallas CH; Steane EA; Shotts SD; Vitsky JL
    Ann Surg; 1994 May; 219(5):517-25; discussion 525-6. PubMed ID: 7514394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation between donor transaminase and recipient hepatitis non-A, non-B in Sweden.
    Widell A; Sundström G; Hansson BG; Fex G; Moestrup T; Nordenfelt E
    Vox Sang; 1988; 54(3):154-9. PubMed ID: 3130727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-HBc testing in an effort to reduce the incidence of posttransfusion non-A, non-B hepatitis.
    Kline WE
    Beitr Infusionther Klin Ernahr; 1987; 18():6-12. PubMed ID: 3125834
    [No Abstract]   [Full Text] [Related]  

  • 36. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmission of non-A, non-B hepatitis.
    Hoofnagle JH; Gerety RJ; Tabor E; Feinstone SM; Barker LF; Purcell RH
    Ann Intern Med; 1977 Jul; 87(1):14-20. PubMed ID: 195505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of routine anti-HBc screening of volunteer blood donors: a questionable surrogate test for non-A, non-B hepatitis.
    Hanson MR; Polesky HF
    Transfusion; 1987; 27(1):107-8. PubMed ID: 3101245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to HBcAg as a means of preventing posttransfusion hepatitis.
    Takano S; Omata M; Ohto M; Satomura Y
    Hepatology; 1993 Aug; 18(2):235-9. PubMed ID: 8393422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.